A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease

[1]  M. Mattson,et al.  A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.

[2]  S. Cunnane,et al.  Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism. , 2013, Nutrition.

[3]  W. Xia,et al.  Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease , 2012, International journal of Alzheimer's disease.

[4]  T. Vanitallie,et al.  Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. , 2012, Regulatory toxicology and pharmacology : RTP.

[5]  K. Clarke,et al.  Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. , 2012, Regulatory toxicology and pharmacology : RTP.

[6]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[7]  D. Clegg,et al.  Dietary ketosis enhances memory in mild cognitive impairment , 2012, Neurobiology of Aging.

[8]  S. M. de la Monte.  Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease , 2012, Current Alzheimer research.

[9]  J. Vogel,et al.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial , 2009, Nutrition & metabolism.

[10]  Young Il Kim,et al.  Insulin Regulation of Skeletal Muscle PDK4 mRNA Expression Is Impaired in Acute Insulin-Resistant States , 2006, Diabetes.

[11]  R. Veech.  The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[12]  M. Reger,et al.  Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.

[13]  T. Vanitallie,et al.  Ketones: metabolism's ugly duckling. , 2003, Nutrition reviews.

[14]  S. Stone-Elander,et al.  Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. , 2002, American journal of physiology. Endocrinology and metabolism.

[15]  Britton Chance,et al.  Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.

[16]  E. Vining.  Clinical efficacy of the ketogenic diet , 1999, Epilepsy Research.

[17]  P. Kerndt,et al.  Fasting: the history, pathophysiology and complications. , 1982, The Western journal of medicine.

[18]  D. Severson,et al.  Regulation of mammalian pyruvate dehydrogenase , 1975, Molecular and Cellular Biochemistry.

[19]  G F Cahill,et al.  Brain metabolism during fasting. , 1967, The Journal of clinical investigation.

[20]  F. Lecocq,et al.  THE EFFECTS OF STARVATION, HIGH FAT DIETS, AND KETONE INFUSIONS ON URIC ACID BALANCE. , 1965, Metabolism: clinical and experimental.

[21]  S. Monte.  Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease , 2012 .

[22]  L. Mosconi,et al.  A tale of two tracers: Glucose metabolism and amyloid positron emission tomography imaging in Alzheimer's disease , 2011 .

[23]  P. Barberger‐Gateau,et al.  Brain fuel metabolism, aging, and Alzheimer's disease. , 2011, Nutrition.